Member States of the World Health Organization have made measurable progress on negotiations for a Pathogen Access and Benefit Sharing (PABS) annex, a critical component of the emerging WHO Pandemic Agreement designed to accelerate and equalize global responses to future infectious disease threats. The framework remains under active negotiation, with participating nations acknowledging that substantial work is required to establish binding commitments on pathogen data and sample sharing across borders.
Key takeaways
- WHO Member States have advanced discussions on the PABS annex, a cornerstone of the proposed WHO Pandemic Agreement
- The annex aims to create faster, more equitable mechanisms for sharing pathogen samples and genomic data during health emergencies
- Negotiators acknowledge that additional rounds of talks are needed before a final agreement can be reached
- The framework is intended to address access disparities that have historically disadvantaged lower-income countries in pandemic preparedness
What the PABS annex seeks to accomplish
The Pathogen Access and Benefit Sharing annex represents an attempt to formalize and accelerate the international exchange of biological samples and genomic sequencing data during public health emergencies. According to the WHO statement on the ongoing negotiations, the framework is designed to enable faster identification of novel pathogens, support vaccine and therapeutic development, and distribute benefits—including access to medical countermeasures—more equitably among nations.
The current negotiations follow the WHO Pandemic Agreement framework, which Member States began developing in response to critical gaps exposed during the COVID-19 pandemic. Historic asymmetries in access to samples and vaccines highlighted the need for binding mechanisms that could ensure lower-income countries receive pathogenic materials and genomic data simultaneously with high-income nations, rather than weeks or months later.
Key Mechanisms of Proposed PABS Framework
Core elements aimed at supporting equitable pathogen and benefit sharing during pandemics
Source: WHO negotiation framework priorities, 2026 | Georgian Medical Journal News
Progress achieved and remaining obstacles
According to the WHO statement released in July 2026, Member States have achieved consensus on fundamental principles underlying equitable pathogen access. However, substantial disagreement persists on implementation mechanisms, enforcement procedures, and the specific obligations of high-income versus low-income nations in contributing samples and sharing financial benefits.
Key sticking points include defining what constitutes “equitable benefit-sharing,” establishing binding timelines for pathogen sample transfers, and clarifying intellectual property protections for countries and institutions that contribute biological materials to research. These negotiations reflect broader tensions between national biosecurity interests and global pandemic preparedness—concerns emphasized in parallel discussions at Global Health forums regarding the balance between transparency and national security.
WHO Member States have advanced negotiations on the Pathogen Access and Benefit Sharing annex, but acknowledge that continued discussions are needed to finalize a framework that supports a faster, more effective, and equitable response to future pandemics.
— World Health Organization, July 2026
Implications for future pandemic preparedness
A finalized PABS annex could fundamentally reshape how the global health system responds to novel pathogens. If Member States reach agreement on binding pathogen-sharing mechanisms, lower-income countries would gain access to samples and genomic data concurrently with wealthy nations, removing barriers to parallel vaccine development and diagnostic testing. This represents a significant shift from the COVID-19 experience, when vaccine inequity became a defining feature of the pandemic response.
The negotiations also touch on Health Policy implications for national laboratory capacity. A functional PABS framework would require investment in biosafety infrastructure, sequencing capabilities, and skilled personnel in lower-resourced countries—strengthening pandemic preparedness infrastructure globally while reducing dependence on a handful of reference laboratories in wealthy nations.
What this means
Frequently asked questions
Why is the PABS annex considered essential for pandemic preparedness?
During the COVID-19 pandemic, lower-income countries often received pathogen samples and genomic data weeks or months after high-income nations, delaying their ability to develop diagnostics and vaccines. A binding PABS annex would mandate simultaneous or near-simultaneous sharing, accelerating global response times and ensuring equitable access to medical countermeasures.
What are the main disagreements blocking a final agreement?
Key disputes centre on defining “equitable benefit-sharing,” establishing enforcement mechanisms for timely pathogen transfers, clarifying intellectual property rights for contributing nations and institutions, and balancing national biosecurity interests with global transparency requirements. High-income and low-income countries hold divergent views on these priorities.
How would a completed PABS annex affect national laboratory systems?
A functional framework would require significant investment in biosafety infrastructure, genomic sequencing capacity, and trained personnel in lower-resourced countries. This could strengthen pandemic preparedness infrastructure globally while reducing dependence on a small number of reference laboratories in wealthy nations.
WHO Member States have signalled a commitment to continuing negotiations on the PABS annex, with the stated goal of establishing a framework that operationalizes equitable pathogen access before the next significant pandemic emerges. The pace and breadth of these discussions will likely define whether the international community can move beyond the fragmented, inequitable responses that characterized COVID-19 and establish genuine global solidarity in infectious disease surveillance and response.
Source: WHO Member States continue negotiations on the Pathogen Access and Benefit Sharing Annex
Was this article helpful?
Related Coverage
